Table 1 References demonstrating the specific association of SUA with cancer risk, recurrence, and mortality
From: Contribution of uric acid to cancer risk, recurrence, and mortality
Reference | Risk category | Gender | Cancer type | SUA measurement |
|---|---|---|---|---|
Petersson et al., 1983 | Unselected | M | All | Concurrent |
Petersson et al., 1984 | Unselected | M | All | Concurrent |
Levine et al., 1989 | Unselected | F | All | Prospective |
Kolonel et al., 1994 | Unselected | M | Prostate | Prospective |
Korenga et al., 2005 | ABCG2 | M/F | Renal | Prospective |
Tsimberidou et al., 2005 | MetS/Obesity | M/F | All | Prospective |
Shin et al., 2006 | Unselected | M/F | All | Concurrent |
Giovannucci, 2007 | MetS | M/F | Colon | Prospective |
Hu et al., 2007 | ABCG2 | M/F | B-Cell Lymphoma | Prospective |
Rose et al., 2007 | MetS | F | Breast | Concurrent |
Strasak et al., 2007a | Unselected | F | All | Prospective |
Strasak et al., 2007b | Unselected | M | All | Prospective |
Boffetta et al., 2009 | Gout | M/F | All | Prospective |
Becker et al., 2009 | Obesity | M/F | All | Concurrent |
Strasak et al., 2009 | Unselected | M/F | All | Prospective |
Bjorge et al., 2011 | MetS | F | Breast | Concurrent |
Hammarsten et al., 2011 | MetS | M | Prostate | Prospective |
Panero, et al., 2011 | T2DM | M/F | All | Prospective |
Siddiqui, 2011 | MetS | M/F | Colorectal | Prospective |
Wang, et al., 2011 | ABCG2 | M/F | Leukemia | Prospective |